Pubblicazioni

elenco delle pubblicazioni e indici bibliometrici Girolamo Francesco

Al 22/2/2026: 75 articoli scientifici editi a stampa (33 articoli decennio 2016-2026 Citazioni ultimi 5 anni (2021-2026): 1378 Scopus h-index ultimi 5 anni (2021-2026) 23. 11 articoli da first author + 3 articoli da co-first author + 6 articoli da second author; 3 articoli da last author + 1 articolo da co-last author; 6 capitoli in altrettanti volumi editi a stampa. Somma impact factor: 207,62; media: 4,14; Scopus h-index: 33; citazioni totali Scopus: 3229

 

 

3.1. PUBBLICAZIONI IN EXTENSO DEGLI ULTIMI 5 ANNI (2021-2026)

 

    1. Vigo T, Voulgari-Kokota A, Errede M, Girolamo F, Ortolan J, Mariani MC, Ferrara G, Virgintino D, Buffo A, Kerlero de Rosbo N, Uccelli A. Mesenchymal stem cells instruct a beneficial phenotype in reactive astrocytes. Glia. 2021;69:1204-1215. doi: 10.1002/glia.23958. [IF: 2019: 5,984] Citazioni Scopus: 0
    2. Giannini M, Fiorella ML, Tampoia M, Girolamo F, Fornaro M, Amati A, Lia A, Abbracciavento L, D’Abbicco D, Iannone F. Long-term efficacy of adding intravenous immunoglobulins as treatment of refractory dysphagia related to myositis: a retrospective analysis. Rheumatology (Oxford). 2021;60:1234-1242. doi:10.1093/rheumatology/keaa443). [IF: 2019: 5,606] Citazioni Scopus: 0
    3. Fornaro M*, Girolamo F*, Cavagna L, Franceschini F, Giannini M, Amati A, Lia A, Tampoia M, D’Abbicco D, Maggi L, Fredi M, Zanframundo G, Moschetti L, Coladonato L, Iannone F. Severe muscle damage with myofiber necrosis and macrophage infiltrates characterize anti-Mi2 positive dermatomyositis. Rheumatology (Oxford), 2021;60(6):2916-2926. doi: 10.1093/rheumatology/keaa739. PMID: 33249503.2020 Nov 29:keaa739. doi: 10.1093/rheumatology/keaa739. (*co-first Authors). [IF: 2019: 5,606] Citazioni Scopus: 0
    4. Lauricella E, d’Amati A, Ingravallo G, Foresio M, Ribatti D, de Tommaso M, Cives M, Girolamo F. Cerebellar ataxia and exercise intolerance in Erdheim-Chester disease. Cerebellum and Ataxias 2021;8:3. https://doi.org/10.1186/s40673-020-00125-x. Citazioni Scopus: 1
    5. Girolamo F, de Trizio I, Errede M, Longo G, d'Amati A, Virgintino D. Neural crest cell-derived pericytes act as pro-angiogenic cells in human neocortex development and gliomas. Fluids and Barrier of the CNS. 2021;18:14. https://doi.org/10.1186/s12987-021-00242-7. [IF: 2019: 4,47] Citazioni Scopus: 3
    6. Yang Y, Ma Y, Lu J, Du S, Zhang J, Meng H, Chen Z, Zhang Q, Zhang X, Shi W, Girolamo F, Cepeda S, Kang J. Evaluation of the reporting quality of clinical practice guidelines on gliomas using the RIGHT checklist. Ann Transl Med. 2021 Jun;9(12):1002. doi: 10.21037/atm-21-2604.
    7. Liu Y, Castano D, Girolamo F, Trigueros-Motos L, Bae HG, Neo SP, Oh J, Narayanaswamy P, Torta F, Rye KA, Jo DG, Gunaratne J, Jung S, Virgintino D, Singaraja RR. Abca8b promotes myelination via regulation of chondroitin sulfate proteoglycan 4 localization in oligodendrocyte precursor cells in mice. 2022 Jan;63(1):100147. doi: 10.1016/j.jlr.2021.100147. [IF: 2021: 5,922] Citazioni Scopus: 0
    8. Lia A, Annese T, Fornaro M, Giannini M, D'Abbicco D, Errede M, Lorusso L, Amati A, Tampoia M, Trojano M, Virgintino D, Ribatti D, Serlenga L, Iannone F, Girolamo F. Perivascular and endomysial macrophages expressing VEGF and CXCL12 promote angiogenesis in anti-HMGCR immune-mediated necrotizing myopathy. Rheumatology (Oxford). 2022 Aug 3;61(8):3448-3460. doi: 10.1093/rheumatology/keab900. PMID: 34864921.
    9. Girolamo F, Errede M, Bizzoca A, Virgintino D, Ribatti D. Central Nervous System Pericytes Contribute to Health and Disease. Cells. 2022 May 20;11(10):1707. doi: 10.3390/cells11101707. PMID: 35626743; PMCID: PMC9139243.
    10. Errede M, Annese T, Petrosino V, Longo G, Girolamo F, de Trizio I, d'Amati A, Uccelli A, Kerlero de Rosbo N, Virgintino D. Microglia-derived CCL2 has a prime role in neocortex neuroinflammation. Fluids Barriers CNS. 2022 Aug 30;19(1):68. doi: 10.1186/s12987-022-00365-5. PMID: 36042496; PMCID: PMC9429625.
    11. Zanfardino P, Longo G, Amati A, Morani F, Picardi E, Girolamo F, Pafundi M, Cox SN, Manzari C, Tullo A, Doccini S, Santorelli FM, Petruzzella V. Mitofusin 2 mutation drives cell proliferation in Charcot-Marie-Tooth 2A fibroblasts. Hum Mol Genet. 2023 Jan 6;32(2):333-350. doi: 10.1093/hmg/ddac201. PMID: 35994048.
    12. Schwab M, de Trizio I, Ghobrial M, Shiu JY, Sürücü O, Girolamo F, Errede M, Yilmaz M, Haybaeck J, Moiraghi A, Monnier PP, Lawler SE, Greenfield JP, Radovanovic I, Frei K, Schlapbach R, Vogel V, Virgintino D, De Bock K, Wälchli T. Nucleolin promotes angiogenesis and endothelial metabolism along the onco-fetal axis in the human brain vasculature. JCI Insight. 2023 Mar 14:e143071. doi: 10.1172/jci.insight.143071. Epub ahead of print. PMID: 36917178.
    13. Girolamo F, Lim YP, Virgintino D, Stonestreet BS, Chen X. Inter-Alpha Inhibitor Proteins Modify the Microvasculature after Exposure to Hypoxia–Ischemia and Hypoxia in Neonatal Rats. Int. J. Mol. Sci. 2023, 24, 6743. https://doi.org/10.3390/ijms24076743
    14. Fornaro M, Girolamo F, Cacciapaglia F, Carabellese G, Bizzoca R, Scioscia C, Coladonato L, Lopalco G, Ruggieri M, Mastrapasqua M, Fari G, D'Abbicco D, Iannone F. Plasma pentraxin 3 in idiopathic inflammatory myopathies: a possible new biomarker of disease activity. Clin Exp Immunol. 2023 Dec 11;214(1):94-102. doi: 10.1093/cei/uxad063. PMID: 37280166; PMCID: PMC10711351.
    15. Mastrapasqua M, Rossi R, De Cosmo L, Resta A, Errede M, Bizzoca A, Zampatti S, Resta N, Giardina E, Ruggieri M, Virgintino D, Annese T, Laforgia N, Girolamo F. Autophagy increase in Merosin-Deficient Congenital Muscular Dystrophy type 1A. Eur J Transl Myol. 2023 Jul 28;33(3):11501. doi: 10.4081/ejtm.2023.11501. PMID: 37522802; PMCID: PMC10583158..
    16. Fornaro M, Coladonato L, Giannini M, Napoletano A, Girolamo F, D'Abbicco D, Ruggieri M, Sabella DVA, Iannone F. Anti-SAE dermatomyositis: clinical and histologic characteristics from a monocentric Italian cohort. Clin Exp Rheumatol. 2024 Feb;42(2):295-301. doi: 10.55563/clinexprheumatol/110r0p. Epub 2024 Mar 14. PMID: 38488098.
    17. Fornaro M, Girolamo F, Giannini M, Coladonato L, Capuano A, Capodiferro M, D'Abbicco D, Ruggieri M, Mastrapasqua M, Iannone F. Clinical, histologic and prognostic features of clinically amyopathic dermatomyositis. Clin Exp Rheumatol. 2024 Feb;42(2):288-294. doi: 10.55563/clinexprheumatol/kgpnbq. Epub 2024 Mar 14. PMID: 38488091.
    18. Zuccaro M, Girolamo F. Anatomical education and its innovations: an interdisciplinary, hands-on, team-building approach. Italian Journal of Anatomy and Embryology. 2024, 128:101-108. doi: 10.36253/ijae-15248.
    19. Massaro A, Cazzato G, Ingravallo G, Casatta N, Lupo C, Vacca A, Iannone F, Girolamo F. Pre-screening of endomysial microvessel density by fast random forest image processing machine learning algorithm accelerates recognition of a modified vascular network in idiopathic inflammatory myopathies. Diagn Pathol. 2025 Jan 31;20(1):13. doi: 10.1186/s13000-025-01608-3. PMID: 39891185; PMCID: PMC11783852.
    20. Guan Y, Luan Y, Zhao S, Li M, Girolamo F, Palmer JD, Guan Q. Single-cell RNA sequencing for characterizing the immune communication and iron metabolism roles in CD31+ glioma cells. Transl Cancer Res. 2025 Apr 30;14(4):2421-2439. doi: 10.21037/tcr-2025-377. Epub 2025 Apr 25. PMID: 40386270; PMCID: PMC12079608.
    21. Faghihi-Kashani S, Yoshida A, Bozan F, Zanframundo G, Rozza D, Loganathan A, Dourado E, Sambataro G, Bauer-Ventura I, et al. participating investigators of Classification Criteria for Anti‐Synthetase Syndrome Project. Clinical Characteristics of Anti-Synthetase Syndrome: Analysis From the Classification Criteria for Anti-Synthetase Syndrome Project. Arthritis Rheumatol. 2025 Apr;77(4):477-489. doi: 10.1002/art.43038. Epub 2024 Dec 17. PMID: 39467037; PMCID: PMC11936500.
    22. Mora A, Girolamo F, Marzullo A, Annese T, De Giorgis M, Signorelli F, Messina R, Ingravallo G, Virgintino D, Errede M, d'Amati A. Navigating the blood-brain barrier to blood-brain tumor barrier transition: microvascular P-glycoprotein and CD146 potentially contribute to glioma grading. Fluids Barriers CNS. 2025 Oct 1;22(1):96. doi: 10.1186/s12987-025-00707-z. PMID: 41034994; PMCID: PMC12486580.
    23. Zanfardino P, Amati A, Doccini S, Girolamo F, Tullo A, Longo G, Santorelli FM, Petruzzella V. Selective mitophagy activation and protein aggregate accumulation in MTMR5/SBF1-deficient fibroblasts. Life Sci. 2025 Nov 15;381:123995. doi: 10.1016/j.lfs.2025.123995. Epub 2025 Sep 23. PMID: 40998285.
    24. Fornaro M, Giannini M, D'Abbicco D, Fiorella ML, Errede M, Virgintino D, Valente O, Frigeri A, Iannone F, Girolamo F. Aquaporin-4 downregulation in dysphagic patients with idiopathic inflammatory myopathies: myofiber vulnerability and inflammation drivers. Rheumatology (Oxford). 2025 Aug 18:keaf436. doi: 10.1093/rheumatology/keaf436. Epub ahead of print. PMID: 40824215.
    25. Prabhudesai S, Thirugnanam K, Song X, Yang H, Errede M, Girolamo F, Neumann T, Marzullo A, Bafti S, Vanderhoef K, Rarick KR, Spearman AD, Pan AY, Alvarez CA, Yang J, Zhang F, Dordick JS, Virgintino D, Wang L, Ramchandran R. Brain vascular stability relies on PAK2-cilia-PDGF-BB-HSPGs on basolateral side of endothelium. Life Sci Alliance. 2026 Jan 5;9(3):e202503460. doi: 10.26508/lsa.202503460. PMID: 41490797
Pubblicato il 26/02/2014 ultima modifica 11/06/2026

Azioni sul documento